Richard Newitter analyst TRUIST

Currently out of the existing stock ratings of Richard Newitter, 320 are a BUY (56.94%), 240 are a HOLD (42.7%), 2 are a SELL (0.36%).

Richard Newitter

Work Performance Price Targets & Ratings Chart

Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 66.72% that have a potential upside of 22.89% achieved within 204 days.

Richard Newitter’s has documented 1,119 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PEN, Penumbra at 16-Jan-2026.

Wall Street Analyst Richard Newitter

Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 4/21/2021. The price target of $286.67 was fulfilled within 1 day with a profit of $10.46 (3.52%) receiving and performance score of 35.2.

Average potential price target upside

ALC Alcon AG ALGN Align Technology AXGN Axogen BDX Becton Dickinson and Company GMED Globus Medical HOLX Hologic INSP Inspire Medical Systems ISRG Intuitive Surgical ITMR Itamar Medical Ltd LNTH Lantheus Holdings NUVA NuVasive SIEN Sientra SYK Stryker TFX Teleflex XENT Intersect ENT ZBH Zimmer Biomet Holdings AXNX Axonics Modulation Technologies CNMD CONMED IART Integra LifeSciences Holdings MDT Medtronic PLC WMGI Wright Medical Group N.V EW Edwards Lifesciences Corp NARI Inari Medical  SPNE SeaSpine Holdings Corp BSX Boston Scientific Corp KIDS Orthopediatrics Corp NVRO Nevro Corp PRCT Procept Biorobotics Corp TMCI Treace Medical Concepts IRTC iRhythm Technologies GKOS Glaukos Corp IRT Independence Realty Trust ITGR Integer Holdings Corp PEN Penumbra VCEL Vericel Corp Ord

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 20-May-2025

10 days ago
(20-Jan-2026)

2/2 (100%)

$14.68 (21.36%)

212

Buy Since 12-Dec-2023

$80

$-0.29 (-0.36%)

$85

21 days ago
(09-Jan-2026)

5/6 (83.33%)

$-0.62 (-0.77%)

96

Buy Since 19-Aug-2021

$91

$10.71 (13.34%)

$91

2 months 6 days ago
(24-Nov-2025)

8/12 (66.67%)

$14.39 (18.78%)

110

Buy Since 10-May-2023

$98

$17.71 (22.06%)

$95

2 months 17 days ago
(13-Nov-2025)

7/12 (58.33%)

$19.39 (24.67%)

285

Buy Since 15-Apr-2019

$100

$19.71 (24.55%)

$110

2 months 18 days ago
(12-Nov-2025)

8/13 (61.54%)

$22.64 (29.27%)

338

Show more analysts

Please expand the browser size to see the chart

Which stock is Richard Newitter is most bullish on?

Potential upside of $124.19 has been obtained for ISRG (INTUITIVE SURGICAL)

Which stock is Richard Newitter is most reserved on?

Potential downside of $0.42 has been obtained for TMCI (TREACE MEDICAL CONCEPTS)

What Year was the first public recommendation made by Richard Newitter?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?